Injective is making a regulatory push in Washington while its token attempts to build a recovery. The INJ price prediction now has two talking points today, first is a potential move toward $70 and the project’s growing engagement with US financial regulators. Neither promotes immediate bullish reaction coming, but both angles put the spotlight back on Injective.
Injective Takes Its Regulatory Ambitions to Washington
Injective announced that its CEO met with officials from the White House, SEC and CFTC this month, alongside the project’s general counsel, head of policy and head of research.
The meetings reflect Injective’s effort to establish a regulatory foundation for tokenization and onchain finance in the United States. More importantly, the project points to several existing milestones rather than relying entirely on future promises.
Injective Institutional Services is an SEC-registered transfer agent providing ownership recordkeeping for tokenized securities. Meanwhile, INJ futures are listed on CFTC-regulated US markets, connecting the ecosystem to regulated financial infrastructure.
Tokenization Plans Could Strengthen Injective’s Position
Injective is developing institutional-grade infrastructure for bringing tokenized stocks, funds and real-world assets onchain. Its legal and policy teams are also engaging with US lawmakers and regulators on digital asset regulation.
These developments could strengthen Injective’s institutional positioning. However, regulatory engagement doesn’t automatically translate into increased token demand or higher prices. That’s where market participants need to separate project progress from speculation.
INJ Price Prediction Faces Critical Resistance Levels
The weekly chart places INJ around $7.64, with $6.52 serving as the foundation of the bullish recovery scenario. Holding that level keeps $15.81 in focus, followed by $33.09.
Beyond $33.09, the previous high near $53 becomes the next major hurdle. A confirmed break above that peak could open the door to price discovery toward $70, although pullbacks and resistance remain part of the projected route in INJ.
For now, the INJ price prediction depends on price confirmation as much as regulatory progress. A sustained weekly breakdown below $6.52 would weaken the bullish roadmap, leaving the $70 target firmly in speculative territory.
Was this writing helpful?
Story Ends Here
Read the Next News